Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889772 · ClinicalTrials.gov registry record
Lung Injury Prediction Study
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 300
- Enrollment target
NCT00889772: Completed study, sponsored by Mayo Clinic.
NCT00889772 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00889772 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of the study is to externally validate the acute lung injury/acute respiratory distress syndrome (ALI/ARDS) prediction model (Lung Injury Prediction Score - LIPS) in a multicenter sample of patients at risk presented to the acute care hospitals: United States Critical Illness and Injury Trials Group (USCIITG).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-02 |
What the finished NCT00889772 record still lists
NCT00889772 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00889772 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00889772 about?
NCT00889772 is a clinical study titled "Lung Injury Prediction Study". The purpose of the study is to externally validate the acute lung injury/acute respiratory distress syndrome (ALI/ARDS) prediction model (Lung Injury Prediction Score - LIPS) in a multicenter sample of patients at risk presented to the acute care hospitals: United States Critical Illness and Injury ...
What is the current status of trial NCT00889772?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2009-03. Estimated completion is 2010-02.
Who is sponsoring clinical trial NCT00889772?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia